Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT06674902
Starting soon Not applicable

Electrolysis in Patients With Chronic Plantar Fasciitis

NCT06674902 · tracked via the Priya Life Science Spain tracker
Sponsor
Wroclaw University of Health and Sport Sciences
Phase
Not applicable
Started
2024-11-11
Last updated
2024-11-05

Condition(s) studied

Plantar Fasciitis

Investigational drug(s) / intervention(s)

Electrolysis Percutaneous Therapeutic (EPTE)

Electrolysis Percutaneous Therapeutic (EPTE): EPTE device (Ionclinics, Valencia, Spain)

Study summary

Aim of the Study

The aim of this study is to investigate the differential effects of high-intensity and low-intensity percutaneous electrolysis (PCE) on pain perception and muscle tissue properties in individuals with chronic plantar fasciitis.

Research Questions

Pain Perception:

Does high-intensity PCE induce greater changes in pressure pain threshold (PPT) in the plantar fascia compared to low-intensity PCE in individuals with chronic plantar fasciitis?

Muscle Tissue Properties:

Does high-intensity PCE reduce stiffness in the plantar fascia to a greater extent than low-intensity PCE in individuals with chronic plantar fasciitis?

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * age 18 years or older, * unilateral heel pain lasting longer than 3 months, * a clinical diagnosis of chronic plantar fasciitis according to the clinical practice guidelines of the Orthopaedic Section of the American Physical Therapy Association (APTA), i.e., sudden onset of pain on the plantar surface of the heel after a period of non-weight bearing, pain that is worse in the morning with the first step, and tenderness to palpation at the proximal attachment site of the plantar fascia. Exclusion Criteria: * previous lower extremity surgery, * the presence of positive neurological signs consistent with nerve root compression, * any medical conditions causing heel pain, such as rheumatoid arthritis, diabetes, or peripheral neuropathy, * receipt of any foot treatment within the past 6 weeks.

Primary outcome measure(s)

  • Pain intensity — Baseline, immediately after
    Participants will rate their pain intensity on an 11-point numeric rating scale (NPRS; 0 = no pain; 10 = worst possible pain). They will consider the pain intensity of their first step in the morning, the average pain intensity during the day, and the maximum pain experienced in the past week. The average of all these values will be used to calculate a pain intensity score for the primary analysis.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Nursery, Physiotherapy and Podiatry Madrid Spain

More Wroclaw University of Health and Sport Sciences trials in Spain

Electrolysis in Patients With Low Back Pain Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06674902 on ClinicalTrials.gov ↗ ← All trials in Spain